Search





Search





Markets
/
Stocks
/
cmmb
/

Chemomab Therapeutics Ltd

CMMB

Add to Watchlist

1.410USD

+0.050+3.68%

Close 07-24 16:00（ET）Quotes delayed by 15 min

40.61MMarket Cap

8.09P/E TTM

Chemomab Therapeutics Ltd

1.410

+0.050+3.68%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey Chart

Intraday

30m

Today

+3.68%

5 Days

-9.62%

1 Month

-11.32%

6 Months

-18.97%

Year to Date

-14.55%

1 Year

-67.66%

Key Figures

1.400Open

1.440High

25.09KVolume

8.09P/E TTM

LossP/E Dynamic

--Dividend TTM

0.09%Turnover Ratio

1.360Prev. Close

1.400Low

20.61KTurnover

LossP/E Static

3.80P/B

0.00%Div Yield TTM

-60.46%ROA

5.56052wk High

0.36Volume Ratio

-13.95MNet Profit

28.80MShares

0.1742EPS TTM

0.61Beta

-70.61%ROE

1.35052wk Low

2.94%Amplitude

--Gross Margin

40.61MMarket Cap

-2.70Reward/Risk

5.36%Risk Rate

Chemomab Therapeutics Ltd News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 2 analysts

Strong Buy

Current Rating

15.000

Target Price

+1002.94%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

496

Total

Median

Average

Company name

Ratings

Analysts

Chemomab Therapeutics Ltd

CMMB

Beigene Ltd

ONC

argenx SE

ARGX

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

Insmed Inc

INSM

...

Indicators

Indicators

Sell(2)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.099

Sell

RSI(14)

38.635

Neutral

STOCH(KDJ)(9,3,3)

2.833

Oversold

ATR(14)

0.232

Low Volatility

CCI(14)

-82.522

Neutral

Williams %R

100.000

Oversold

TRIX(12,20)

-0.646

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.432

Sell

MA10

1.494

Sell

MA20

1.723

Sell

MA50

1.724

Sell

MA100

1.720

Sell

MA200

1.986

Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Chemomab Therapeutics Ltd Info

Chemomab Therapeutics Ltd (formerly known as Anchiano Therapeutics Ltd) is a Israel-based clinical-stage biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of fibrotic and inflammatory diseases with high unmet medical need among others. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.

Ticker SymbolCMMB

CompanyChemomab Therapeutics Ltd

CEOMor (Adi)

Websitehttps://www.chemomab.com/